These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1653835)
1. Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. Mimeault M; Fournier A; Dumont Y; St-Pierre S; Quirion R J Pharmacol Exp Ther; 1991 Sep; 258(3):1084-90. PubMed ID: 1653835 [TBL] [Abstract][Full Text] [Related]
2. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. Dennis T; Fournier A; Cadieux A; Pomerleau F; Jolicoeur FB; St Pierre S; Quirion R J Pharmacol Exp Ther; 1990 Jul; 254(1):123-8. PubMed ID: 2164085 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. Dennis T; Fournier A; St Pierre S; Quirion R J Pharmacol Exp Ther; 1989 Nov; 251(2):718-25. PubMed ID: 2553933 [TBL] [Abstract][Full Text] [Related]
4. Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues. Van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R J Pharmacol Exp Ther; 1994 May; 269(2):846-53. PubMed ID: 8182554 [TBL] [Abstract][Full Text] [Related]
5. A potent and selective CGRP2 agonist, [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. Dumont Y; Fournier A; St-Pierre S; Quirion R Can J Physiol Pharmacol; 1997 Jun; 75(6):671-6. PubMed ID: 9276147 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. Mimeault M; Quirion R; Dumont Y; St-Pierre S; Fournier A J Med Chem; 1992 Jun; 35(12):2163-8. PubMed ID: 1319490 [TBL] [Abstract][Full Text] [Related]
7. Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain. van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R J Pharmacol Exp Ther; 1994 Aug; 270(2):779-87. PubMed ID: 8071870 [TBL] [Abstract][Full Text] [Related]
8. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors. Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766 [TBL] [Abstract][Full Text] [Related]
9. Photoaffinity labeling of rat calcitonin gene-related peptide receptors and adenylate cyclase activation: identification of receptor subtypes. Stangl D; Muff R; Schmolck C; Fischer JA Endocrinology; 1993 Feb; 132(2):744-50. PubMed ID: 8381072 [TBL] [Abstract][Full Text] [Related]
10. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity. Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic study of C-terminal fragments of frog skin calcitonin gene-related peptide. Ladram A; Besné I; Breton L; de Lacharrière O; Nicolas P; Amiche M Peptides; 2008 Jul; 29(7):1150-6. PubMed ID: 18395938 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Wisskirchen FM; Burt RP; Marshall I Br J Pharmacol; 1998 Apr; 123(8):1673-83. PubMed ID: 9605575 [TBL] [Abstract][Full Text] [Related]
13. Effect of dithiothreitol and Gpp(NH)p on [125I] alpha-hCGRP binding sites in brain and peripheral tissues. Van Rossum D; Dumont Y; Fournier A; St-Pierre S; Quirion R Ann N Y Acad Sci; 1992 Jun; 657():429-31. PubMed ID: 1322095 [No Abstract] [Full Text] [Related]
14. Calcitonin gene-related peptide (hCGRP alpha) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences. Dennis T; Fournier A; Guard S; St Pierre S; Quirion R Brain Res; 1991 Jan; 539(1):59-66. PubMed ID: 1849780 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of calcitonin gene-related peptide on excitation and contraction of smooth muscles of the rat vas deferens. Goto K; Kimura S; Saito A J Pharmacol Exp Ther; 1987 May; 241(2):635-41. PubMed ID: 3494840 [TBL] [Abstract][Full Text] [Related]
16. Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations. Giuliani S; Wimalawansa SJ; Maggi CA Br J Pharmacol; 1992 Oct; 107(2):510-4. PubMed ID: 1330181 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor. Wu D; Eberlein W; Rudolf K; Engel W; Hallermayer G; Doods H Eur J Pharmacol; 2000 Jul; 400(2-3):313-9. PubMed ID: 10988349 [TBL] [Abstract][Full Text] [Related]
18. Human alpha-calcitonin gene-related peptide-(8-37) as an antagonist of exogenous and endogenous calcitonin gene-related peptide. Maggi CA; Chiba T; Giuliani S Eur J Pharmacol; 1991 Jan; 192(1):85-8. PubMed ID: 2040366 [TBL] [Abstract][Full Text] [Related]
19. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction. Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898 [TBL] [Abstract][Full Text] [Related]